BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ying J, Xu Q, Liu B, Zhang G, Chen L, Pan H. The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis. Onco Targets Ther. 2015;8:2427-2433. [PMID: 26366097 DOI: 10.2147/ott.s88592] [Cited by in Crossref: 30] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Kumar R, Mahmoud MM, Tashkandi HM, Haque S, Harakeh S, Ponnusamy K, Haider S. Combinatorial Network of Transcriptional and miRNA Regulation in Colorectal Cancer. IJMS 2023;24:5356. [DOI: 10.3390/ijms24065356] [Reference Citation Analysis]
2 Ding C, Zhang Q, Jiang X, Wei D, Xu S, Li Q, Wu M, Wang H. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics. Comput Math Methods Med 2022;2022:4321466. [PMID: 35756405 DOI: 10.1155/2022/4321466] [Reference Citation Analysis]
3 Guo J, Li X, Miao L, Sun H, Gao X, Guo S, Zhang Y, Cong P, Chen W. High-Throughput Sequencing Reveals the Differential MicroRNA Expression Profiles of Human Gastric Cancer SGC7901 Cell Xenograft Nude Mouse Models Treated with Traditional Chinese Medicine Si Jun Zi Tang Decoction. Evid Based Complement Alternat Med 2021;2021:6119212. [PMID: 34457026 DOI: 10.1155/2021/6119212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liu J, Feng W, Liu M, Rao H, Li X, Teng Y, Yang X, Xu J, Gao W, Li L. Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling. Bosn J Basic Med Sci 2021;21:434-46. [PMID: 33259779 DOI: 10.17305/bjbms.2020.4978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang J, Zhang F, Fan J, Feng B. TGIF1 Knockdown Inhibits the Proliferation and Invasion of Gastric Cancer via AKT Signaling Pathway. Cancer Manag Res 2021;13:2603-12. [PMID: 33776478 DOI: 10.2147/CMAR.S254348] [Reference Citation Analysis]
6 Yao Z, Gao G, Yang J, Long Y, Wang Z, Hu W, Liu Y. Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis. Front Oncol 2020;10:588200. [PMID: 33363017 DOI: 10.3389/fonc.2020.588200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Allam L, Arrouchi H, Ghrifi F, El Khazraji A, Kandoussi I, Bendahou MA, El Amri H, El Absi M, Ibrahimi A. AKT1 Polymorphism (rs10138227) and Risk of Colorectal Cancer in Moroccan Population: A Case Control Study. Asian Pac J Cancer Prev 2020;21:3165-70. [PMID: 33247671 DOI: 10.31557/APJCP.2020.21.11.3165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Spirina LV, Avgustinovich AV, Afanasiev SG, Volkov MY. Influence of neoadjuvant therapy on the expression of molecular markers in gastric cancer. Malignant Tumours 2020;10:29-34. [DOI: 10.18027/2224-5057-2020-10-29-34] [Reference Citation Analysis]
9 Cai C, Dang W, Liu S, Huang L, Li Y, Li G, Yan S, Jiang C, Song X, Hu Y, Gu J. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway. Cancer Sci. 2020;111:1132-1145. [PMID: 31977138 DOI: 10.1111/cas.14326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
10 Zhou W, Wu J, Zhu Y, Meng Z, Liu X, Liu S, Ni M, Jia S, Zhang J, Guo S. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology. BMC Complement Med Ther 2020;20:6. [PMID: 32020871 DOI: 10.1186/s12906-019-2787-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
11 Yang JH, Yu K, Si XK, Li S, Cao YJ, Li W, Zhang JX. Liensinine inhibited gastric cancer cell growth through ROS generation and the PI3K/AKT pathway. J Cancer 2019;10:6431-8. [PMID: 31772676 DOI: 10.7150/jca.32691] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
12 Bao L, Li X. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma. Mol Cell Biochem 2019;460:67-79. [PMID: 31218569 DOI: 10.1007/s11010-019-03571-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
13 Zhang L, Wu Q, He C, Liang D, Yi Q, Shi J, Wan B, Yang R, Li L, Sha S, Chang Q. HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression. Dig Liver Dis 2019;51:157-65. [PMID: 30314948 DOI: 10.1016/j.dld.2018.08.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
14 Canzonieri V, Rao F, Perin T, Alessandrini L, Buonadonna A, Bertola G, Belluco C, Cannizzaro R, De Paoli A, Giordano A. Diagnostic, Prognostic, Predictive and Therapeutic Tissue Biomarkers in Gastric Cancer. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_5] [Reference Citation Analysis]
15 Wu N, Du Z, Zhu Y, Song Y, Pang L, Chen Z. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat 2018;17:1533033818758772. [PMID: 29463194 DOI: 10.1177/1533033818758772] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
16 Chen C, Maimaiti A, Zhang X, Qu H, Sun Q, He Q, Yu W. Knockdown of RAI14 suppresses the progression of gastric cancer. Onco Targets Ther 2018;11:6693-703. [PMID: 30349303 DOI: 10.2147/OTT.S175502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
17 Meena NK, Pattanayak SP, Ben-Nun Y, Benhamron S, Kumar S, Merquiol E, Hövelmeyer N, Blum G, Tirosh B. mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity. Immunology 2018;155:505-18. [PMID: 30144045 DOI: 10.1111/imm.12996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Wang XS, Ding XZ, Li XC, He Y, Kong DJ, Zhang L, Hu XC, Yang JQ, Zhao MQ, Gao SG, Lin TY, Li Y. A highly integrated precision nanomedicine strategy to target esophageal squamous cell cancer molecularly and physically. Nanomedicine 2018;14:2103-14. [PMID: 30047470 DOI: 10.1016/j.nano.2018.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
19 Long ZW, Wu JH, Cai-Hong, Wang YN, Zhou Y. MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway. Mol Cells. 2018;41:532-544. [PMID: 29902839 DOI: 10.14348/molcells.2018.2211] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
20 Wang Y, Zhang H, Lin M, Wang Y. Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population. Cancer Manag Res 2018;10:1305-11. [PMID: 29872343 DOI: 10.2147/CMAR.S164084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Liu X, Wu J, Zhang D, Wang K, Duan X, Meng Z, Zhang X. Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer. Evid Based Complement Alternat Med 2018;2018:7802639. [PMID: 29853970 DOI: 10.1155/2018/7802639] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
22 Xue W, Wang M, Zhang L, Gu J, Zhu X, Wang Y, Wang R, Wang L, Wang W, Wang XF, Mei JW, Zheng L, Zhu ML. Genetic Variants Within MTORC1 Genes Predict Gastric Cancer Prognosis in Chinese Populations. J Cancer 2018;9:1448-54. [PMID: 29721055 DOI: 10.7150/jca.23566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Lu J, Chen M, Gao S, Yuan J, Zhu Z, Zou X. LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2. Oncol Lett 2018;15:4358-64. [PMID: 29541204 DOI: 10.3892/ol.2018.7843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
24 Li Y, Liu Y, Shi F, Cheng L, She J. Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells via the PI3K/Akt/mTOR Pathway. Oncol Res 2016;24:287-93. [PMID: 27712585 DOI: 10.3727/096504016X14648701447779] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
25 Piddock RE, Bowles KM, Rushworth SA. The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma. Cancers (Basel) 2017;9:E29. [PMID: 28350342 DOI: 10.3390/cancers9040029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
26 Chen P, Jin Q, Fu Q, You P, Jiang X, Yuan Q, Huang H. Induction of Multidrug Resistance of Acute Myeloid Leukemia Cells by Cocultured Stromal Cells via Upregulation of the PI3K/Akt Signaling Pathway. Oncol Res 2016;24:215-23. [PMID: 27656831 DOI: 10.3727/096504016X14634208143021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
27 Fang WL, Huang KH, Lan YT, Lin CH, Chang SC, Chen MH, Chao Y, Lin WC, Lo SS, Li AF. Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers. Oncotarget. 2016;7:6201-6220. [PMID: 26701847 DOI: 10.18632/oncotarget.6641] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
28 Pu F, Chen F, Shao Z. MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma. Tumour Biol 2016. [PMID: 27730542 DOI: 10.1007/s13277-016-5468-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
29 Hu QL, Wang HB, Yang M. Significance of expression of INPP4B in gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(16): 2478-2484 [DOI: 10.11569/wcjd.v24.i16.2478] [Reference Citation Analysis]
30 Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L. Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer. Onco Targets Ther 2016;9:2975-86. [PMID: 27284247 DOI: 10.2147/OTT.S95129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
31 Wu YR, Qi HJ, Deng DF, Luo YY, Yang SL. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol 2016;37:12061-70. [PMID: 27188433 DOI: 10.1007/s13277-016-5074-2] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 11.3] [Reference Citation Analysis]
32 Wu M, Ye X, Deng X, Wu Y, Li X, Zhang L. Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma. Onco Targets Ther 2016;9:1647-56. [PMID: 27051300 DOI: 10.2147/OTT.S96518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]